European Medicines Agency Validates Gilead's Marketing Authorization Application for Lenacapavir, an Investigational, Long-Acting Capsid Inhibitor for the Treatment of HIV-1 in People With Limited Therapy Options Biotech Investing
Bristol Myers Squibb Receives European Commission Approval for Abecma , the First Anti-BCMA CAR T Cell Therapy for Relapsed and Refractory Multiple Myeloma Biotech Investing
BriaCell and ImaginAb Announce Collaboration to Evaluate Immunotherapy Imaging Technology in Advanced Breast Cancer Biotech Investing
New England Journal of Medicine Publishes 12-Week Results from Study Evaluating Atogepant for the Preventive Treatment of Migraine Biotech Investing
Winning Formulation; Lexaria Takes Strategic Aim at High Value Hypertension and Antiviral Therapeutics Markets with Robust Drug Delivery Technology Biotech Investing
EMA Validates Bristol Myers Squibb's Applications for Opdivo + Yervoy and Opdivo + Chemotherapy as First-Line Treatments for Unresectable Advanced, Recurrent or Metastatic Esophageal Squamous Cell Carcinoma Biotech Investing
Aurinia Acquires Novel Pipeline Assets Targeting Autoimmune and Kidney-related Diseases Biotech Investing
